Manager × security

ALETHEA CAPITAL MANAGEMENT, LLC AXSM holdings history

Who else holds this security? →

AXSOME THERAPEUTICS INC · CUSIP 05464T104 · CIK 1549408

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, ALETHEA CAPITAL MANAGEMENT, LLC reported 648.76K AXSM (shares), valued at $158.80M, or 65.78% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
65.78%
Shares
648.76K
648,756
Reported value
$158.80M
USD

Shares decreased 0.06%; reported value increased 44.74%, and weight changed +6.84 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 202665.78%648,756SEC filing ↗Filed Aug 14, 2026
Q1 202658.94%649,114SEC filing ↗Filed May 13, 2026
Q4 202559.30%668,710SEC filing ↗Filed Feb 11, 2026
Q3 202552.44%670,883SEC filing ↗Filed Nov 14, 2025
Q2 202552.72%667,368SEC filing ↗Filed Aug 14, 2025
Q1 202558.07%667,368SEC filing ↗Filed May 14, 2025
Q4 202453.19%734,317SEC filing ↗Filed Feb 14, 2025
Q3 202447.94%738,503SEC filing ↗Filed Nov 14, 2024
Q2 202445.25%740,888SEC filing ↗Filed Aug 15, 2024
Q1 202448.02%740,791SEC filing ↗Filed May 16, 2024
Q4 202369.06%752,044SEC filing ↗Filed Feb 15, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 202369.06%752,044$59.86MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 15, 2024
Q1 202448.02%740,791$59.12MShares decreased 1.50%; reported value decreased 1.24%, and weight changed -21.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 16, 2024
Q2 202445.25%740,888$59.64MShares increased 0.01%; reported value increased 0.89%, and weight changed -2.77 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 15, 2024
Q3 202447.94%738,503$66.37MShares decreased 0.32%; reported value increased 11.28%, and weight changed +2.69 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 202453.19%734,317$62.13MShares decreased 0.57%; reported value decreased 6.39%, and weight changed +5.25 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 202558.07%667,368$77.84MShares decreased 9.12%; reported value increased 25.28%, and weight changed +4.88 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2025
Q2 202552.72%667,368$69.67MShares unchanged; reported value decreased 10.49%, and weight changed -5.35 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 202552.44%670,883$81.48MShares increased 0.53%; reported value increased 16.96%, and weight changed -0.28 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 202559.30%668,710$122.13MShares decreased 0.32%; reported value increased 49.90%, and weight changed +6.86 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 11, 2026
Q1 202658.94%649,114$109.71MShares decreased 2.93%; reported value decreased 10.17%, and weight changed -0.36 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 13, 2026
Q2 202665.78%648,756$158.80MShares decreased 0.06%; reported value increased 44.74%, and weight changed +6.84 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
ALETHEA CAPITAL MANAGEMENT, LLC · AXSOME THERAPEUTICS INC

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1549408","quarter":"2026Q2","cusip":"05464T104"}

get_institutional_manager_history
{"cik":"1549408","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.